510(k) Report

510(k) · Cleared

Cleared

IDx-DR v2.3

K213037510(k) TraditionalCleared Jun 17, 2022269-day reviewClass II21 CFR 886.1100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Digital Diagnostics, Inc. · PIB Diabetic Retinopathy Detection Device

Cleared on Jun 17, 2022 as substantially equivalent to K203629 (Digital Diagnostics, Inc., 2021) after a 269-day review. Its family tree reaches back 2 generations to 2018.

Decided
Jun 17, 2022
Review
269 days
Class
Class II
Product code
PIB
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN180001 (2018). No later device cites it as a predicate yet.

DEN180001 · IDx-DR · Idx, LLC · 2018K203629 · IDx-DR · Digital Diagnostics, Inc. · 202120162018202020222024
  1. Root · 2 generations backDEN180001 IDx-DRIdx, LLC · 2018
  2. 1 generation backK203629 IDx-DRDigital Diagnostics, Inc. · 2021
  3. This deviceK213037 IDx-DR v2.3Digital Diagnostics, Inc. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN180001IDx-DRIdx, LLC2018—
−1K203629IDx-DRDigital Diagnostics, Inc.2021—
0 (this device)K213037IDx-DR v2.3Digital Diagnostics, Inc.2022—
FIG. 1 — Lineage of K213037, 2018–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PIB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PIB device

  1. #1 K253704 iPredict-DRscore 11.9 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K203629IDx-DR
Summary page 5
…osed with diabetic retinopathy. IDx-DR is indicated for use with the Topcon NW400. V. Predicate Device IDx-DR, Diabetic Retinopathy Detection Device, K203629 This predicate has not been subject to a design-related recall. No reference devices were used in this submission.…
Digital Diagnostics, Inc.2021—

Also cleared against K203629: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 3.2 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K203629.

How does its category compare?

All PIB devices

PIB Diabetic Retinopathy Detection Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · PIB

1in 2024

2018: 12020: 12021: 12022: 22023: 12024: 12026 (partial year): 1
2007high 2 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PIB

Too few PIB 510(k)s in any year since 2007 to give a median.

Recalls per year · PIB

No recall names PIB since 2007.

Adverse event reports per year · PIB

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2025

MAUDE reports naming product code PIB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20190—00
20201—00
20211—00
20222—00
20231—00
20241—00
20250—01
20261—0—

What is it indicated for?

IDx-DR is indicated for use by healthcare providers to automatically detect more than mild diabetic retinopathy (mtmDR) in adults diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy. IDx-DR is indicated for use with the Topcon NW400.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K213037: IDx-DR v2.3.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213037

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026